The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…
Active Awarded Last action
- Contract number
- 75N93021D00009
- Awardee
-
Creagen Inc. UEI TR7EMJYU1KL9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $8,746 obligated
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Combined order value
- $8,746 Current and potential, with all options
- Last date to order 86% complete
- IDV ceiling <1% used
- $107,274,471.00
- Maximum order
- $107,274,471.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded this multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide preclinical development support for candidate products and drug development activities related to HIV, hepatitis B, hepatitis C, and tuberculosis. The $107.3 million contract has a 7-year period of performance and encompasses seven task areas, including in vitro testing, synthesis of therapeutic agents, animal models, formulation development, preclinical pharmacology/toxicology, and a reagent program. Task Area B for synthesis of therapeutic agents is set aside for small business concerns. The contract was awarded to Creagen Inc., an 8(a) small business, and provides for the issuance of fixed-price and cost-reimbursement task orders over the 7-year term. The initial task orders fund a quality assurance/quality control plan and the guaranteed minimum contract amount.
Description
The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/o
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93021D00009?
75N93021D00009 was awarded to Creagen Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021D00009 worth?
Orders under 75N93021D00009 have obligated $8,746. 75N93021D00009's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.
How many orders have been placed under contract 75N93021D00009?
2 orders have been placed under 75N93021D00009, the latest on April 15, 2021.
Who can order from contract 75N93021D00009?
75N93021D00009 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93021D00009 part of a contract vehicle?
Yes. 75N93021D00009 is part of Preclinical Services for HIV Therapeutics.
Was contract 75N93021D00009 competed?
The extent of competition for 75N93021D00009 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV